FLT3-positive Relapsed/Refractory Acute Myeloid Leukemia
1 clinical trials · Condition
◉ Watch FLT3-positive Relapsed/Refractory Acute Myeloid Leukemia
| Record | Firm | Date |
|---|---|---|
| TAA05 Injection in the Treatment of Adult Patients With FLT3-positive Relapsed/Refractory Acute Myeloid Leukemia (NCT05432401) | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2022-06-09 |
Track FLT3-positive Relapsed/Refractory Acute Myeloid Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.